BLACK DIAMOND THERAPEUTICS I shareholders Q3 2023

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

BLACK DIAMOND THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
OCCUDO QUANTITATIVE STRATEGIES LP 26,762$76,8070.01%
Candriam S.C.A. 500,009$1,435,0260.01%
Point72 Asset Management, L.P. 1,115,000$3,200,0500.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 126,500$363,0550.01%
BOOTHBAY FUND MANAGEMENT, LLC 119,762$343,7170.01%
T. Rowe Price Investment Management, Inc. 2,153,588$6,1810.00%
ALGERT GLOBAL LLC 19,820$570.00%
Schonfeld Strategic Advisors LLC 149,100$427,9170.00%
Renaissance Technologies 328,900$9440.00%
Tower Research Capital LLC (TRC) 7,850$22,5290.00%
Jump Financial, LLC 11,272$32,3510.00%
BARCLAYS PLC 322,246$9250.00%
TWO SIGMA INVESTMENTS, LP 80,124$229,9560.00%
MILLENNIUM MANAGEMENT LLC 375,751$1,078,4050.00%
MOORE CAPITAL MANAGEMENT, LP 22,654$65,0170.00%
DIMENSIONAL FUND ADVISORS LP 52,258$149,9810.00%
US BANCORP \DE\ 700$2,0090.00%
BANK OF AMERICA CORP /DE/ 596$1,7110.00%
PNC FINANCIAL SERVICES GROUP, INC. 1,000$2,8700.00%
STIFEL FINANCIAL CORP 20,100$57,6870.00%
External links

This page lists BLACK DIAMOND THERAPEUTICS I's shareholders in Q3 2023. To view BLACK DIAMOND THERAPEUTICS I's shareholder history, click here.